Also categorized in PubMed:
Treatment of chronic graft versus host disease with bortezomib.
x hide permanently

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.

ncbi.nlm.nih.gov

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.

Oncotarget. 2017 Oct 13;8(48):83768-83780

Authors: Petrov I, Suntsova M, Ilnitskaya E, Roumiantsev S, Sorokin M, Garazha A, Spirin P, Lebedev T, Gaifullin N, Larin S, Kovalchuk O, Konovalov D, Prassolov V, Roumiantsev A, Buzdin A

Mentions: MYCN